Compounds > adefovir
Page last updated: 2024-08-24

adefovir and lithocholic acid

adefovir has been researched along with lithocholic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biessen, EA; Bijsterbosch, MK; de Vrueh, RL; Rump, ET; Sliedregt, LA; van Berkel, TJ1
Balzarini, J; Biessen, EA; Bijsterbosch, MK; de Vrueh, RL; Rump, ET; van Berkel, TJ; van De Bilt, E; van Veghel, R1
Biessen, EA; Bijsterbosch, MK; de Clercq, E; de Vrueh, RL; Neyts, J; van Berkel, TJ; Ying, C1

Other Studies

3 other study(ies) available for adefovir and lithocholic acid

ArticleYear
Synthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrier.
    Pharmaceutical research, 1999, Volume: 16, Issue:8

    Topics: Adenine; Animals; Antiviral Agents; Drug Carriers; Drug Delivery Systems; Humans; Lipoproteins, HDL; Lithocholic Acid; Liver; Organophosphonates; Prodrugs; Rats; Tritium

1999
Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3

    Topics: Adenine; Animals; Antiviral Agents; Chromatography; Drug Carriers; Hepatitis B; Lipoproteins, HDL; Lithocholic Acid; Liver; Male; Organophosphonates; Prodrugs; Rats; Rats, Wistar; Tissue Distribution; Tritium

2000
Carrier-mediated delivery improves the efficacy of 9-(2-phosphonylmethoxyethyl)adenine against hepatitis B virus.
    Molecular pharmacology, 2001, Volume: 60, Issue:3

    Topics: Adenine; Anti-Inflammatory Agents, Non-Steroidal; Drug Carriers; Drug Delivery Systems; Hepatitis B virus; Humans; Lactose; Lipoproteins, HDL; Lithocholic Acid; Microbial Sensitivity Tests; Organophosphonates; Tumor Cells, Cultured; Virus Replication

2001